Literature DB >> 17661183

A novel MSH2 germline mutation in a Druze HNPCC family.

Jamal Zidan1, Renée C Niessen, Yael Laitman, Dennie Rozeveld, Robert M W Hofstra, Eitan Friedman.   

Abstract

Germline mutations in DNA mismatch repair (DNA-MMR) genes, mainly MLH1, MSH2, and MSH6, underlie Hereditary non-polyposis colorectal cancer (HNPCC) and are mostly family-specific, with few reported founder mutations in MSH2 (Ashkenazim) MLH1 (Finnish). No mutations in colon cancer susceptibility genes have ever been reported in Druze individuals, a Moslem related faith encompassing approximately 1,000,000 individuals worldwide. A novel MSH2 mutation is described in a Druze HNPCC family: a multigenerational family with 10 members in 4 generations affected with colorectal cancer (mean age of diagnosis 46.5 years), two with gastric cancer and one--endometrial cancer. Mutational analysis of the MSH2 gene using denaturing gradient gel electrophoresis (DGGE) and direct sequencing revealed the c.702delA mutation in codon 234 of exon 4 of the MSH2 gene leading to a premature early stop in codon 245, p.Thr234fsX245. Analysis of mutation-carrying or presumed carriers individuals' offspring, revealed 11/42 asymptomatic mutation carriers, age range 17-50 years. The mutation was not present in two additional Druze HNPCC families and 20 Druze sporadic colon cancer patients. This is the first mutation ever reported in a colon cancer susceptibility gene in a Druze family and it appears not to be a founder mutation in Druze individuals with HNPCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661183     DOI: 10.1007/s10689-007-9157-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  32 in total

1.  Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer.

Authors:  A L Moisio; P Sistonen; J Weissenbach; A de la Chapelle; P Peltomäki
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

2.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

Review 3.  The tumor spectrum in the Lynch syndrome.

Authors:  Patrice Watson; Bronson Riley
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.

Authors:  S Syngal; E A Fox; C Li; M Dovidio; C Eng; R D Kolodner; J E Garber
Journal:  JAMA       Date:  1999-07-21       Impact factor: 56.272

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Authors:  W D Foulkes; I Thiffault; S B Gruber; M Horwitz; N Hamel; C Lee; J Shia; A Markowitz; A Figer; E Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; J N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; A De La Chapelle; J Boyd; K Offit; G Rennert; G Chong; N A Ellis
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

7.  MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis.

Authors:  Y Wu; M Nyström-Lahti; J Osinga; M W Looman; P Peltomäki; L A Aaltonen; A de la Chapelle; R M Hofstra; C H Buys
Journal:  Genes Chromosomes Cancer       Date:  1997-04       Impact factor: 5.006

Review 8.  Hereditary colorectal cancer syndromes.

Authors:  Lisa L Strate; Sapna Syngal
Journal:  Cancer Causes Control       Date:  2005-04       Impact factor: 2.506

9.  Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene.

Authors:  D J Gross; N Avishai; V Meiner; D Filon; B Zbar; D Abeliovich
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

10.  Identification of two mutations for ataxia telangiectasia among the Druze community.

Authors:  Fuad Fares; Sivan Axelord Ran; Miriam David; Nathanel Zelnik; Yehudah Hecht; Hasan Khairaldeen; Aaron Lerner
Journal:  Prenat Diagn       Date:  2004-05       Impact factor: 3.050

View more
  1 in total

1.  Colorectal cancer in young patients: is it a distinct clinical entity?

Authors:  Hadar Goldvaser; Ofer Purim; Yulia Kundel; Daniel Shepshelovich; Tzippy Shochat; Lital Shemesh-Bar; Aaron Sulkes; Baruch Brenner
Journal:  Int J Clin Oncol       Date:  2016-01-28       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.